TARGETING THE HOX TRANSCRIPTION FACTORS AND CD71 IN MULTIPLE MYELOMA

被引:0
|
作者
Daniels, Tracy R. [1 ]
Neacato, Isabel I. [1 ]
Rodriguez, Jose A. [1 ,2 ]
Pandha, Hardev S. [3 ]
Morgan, Richard [3 ]
Penichet, Manuel L. [1 ,2 ,4 ,5 ]
机构
[1] Univ Calif Los Angeles, Dept Surg, Div Surg Oncol, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA
[3] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
494
引用
收藏
页码:6107 / 6108
页数:2
相关论文
共 50 条
  • [1] Targeting HOX transcription factors in prostate cancer
    Richard Morgan
    Angie Boxall
    Kevin J Harrington
    Guy R Simpson
    Agnieszka Michael
    Hardev S Pandha
    BMC Urology, 14
  • [2] Targeting HOX transcription factors in prostate cancer
    Morgan, Richard
    Boxall, Angie
    Harrington, Kevin J.
    Simpson, Guy R.
    Michael, Agnieszka
    Pandha, Hardev S.
    BMC UROLOGY, 2014, 14
  • [3] Targeting transcription factors in multiple myeloma: evolving therapeutic strategies
    Li, Shirong
    Vallet, Sonia
    Sacco, Antonio
    Roccaro, Aldo
    Lentzsch, Suzanne
    Podar, Klaus
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (05) : 445 - 462
  • [4] Ruminant cluster CD71
    Naessens, J
    Davis, WC
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 52 (04) : 257 - 258
  • [5] Targeting HOX and PBX transcription factors in ovarian cancer
    Richard Morgan
    Lynn Plowright
    Kevin J Harrington
    Agnieszka Michael
    Hardev S Pandha
    BMC Cancer, 10
  • [6] Targeting HOX and PBX transcription factors in ovarian cancer
    Morgan, Richard
    Plowright, Lynn
    Harrington, Kevin J.
    Michael, Agnieszka
    Pandha, Hardev S.
    BMC CANCER, 2010, 10
  • [7] CD71与IgA肾病
    兰颖
    中国中西医结合肾病杂志, 2010, 11 (04) : 365 - 367
  • [8] Expression of CD71/Gly A and CD71/CD33 in peripheral blood samples in essential thrombocythemia and polycythemia vera
    Gonzalez, N
    Mendoza, MC
    Sanz, EG
    Cesar, J
    Sanz, E
    Burgaleta, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 313 - 313
  • [9] Development of a probody drug conjugate (PDC) targeting CD71 for the treatment of solid tumors and lymphomas
    Singh, Shweta
    DuPage, Amy
    Weaver, Annie Yang
    Sager, Jason
    White, Clayton
    Krimm, Michael
    Huang, Yuanhui
    Diep, Linnea
    Tipton, Kim
    Liu, Shouchun
    Richardson, Jennifer
    Kavanaugh, W. Michael
    Terrett, Jonathan A.
    Desnoyers, Luc R.
    CANCER RESEARCH, 2016, 76
  • [10] Targeting myeloma cell growth factors in multiple myeloma
    Klein, B.
    Hose, D.
    Moreaux, J.
    De Vos, J.
    Jourdan, M.
    Sprinsky, A. C.
    Jourdan, E.
    Reme, T.
    Mahtouk, K.
    Goldschmidt, H.
    Rossi, J. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 43 - 44